Abstract
Purpose
Microvascular disease (MVD) is associated with amputation linked to peripheral artery disease (PAD) in the general population. No study evaluated the impact of diabetic microvascular complications on the outcomes of vascular diabetic foot ulcers (DFU). The aim of the study was to investigate whether retinopathy, nephropathy, and polyneuropathy can predict the outcomes of DFU in type 2 diabetic patients with PAD.
Methods
Three hundred and thirty-one consecutive patients with vascular DFU were enrolled and followed up for 44.1 ± 23.9 months.
Results
The prevalence of retinopathy was significantly higher in subjects with ulcer persistence (45.2%; p < 0.01), minor amputation (48.9%; p < 0.001), and major amputation (57.9%; p < 0.001) than in healed patients (23.3%), and in non-survivors than in survivors (64.9 versus 20.5%; p < 0.001). The prevalence of nephropathy was significantly greater in subjects with ulcer persistence (83.9%; p < 0.01), minor amputation (86.7%; p < 0.001), and major amputation (94.7%; p < 0.001) than in those with healed DFU (64.4%), and in non-survivors than in survivors (88.3 versus 65.7%; p < 0.001). The prevalence of polyneuropathy was significantly higher in non-survivors than in survivors (76.6 versus 61.0%; p = 0.012). Multivariate analysis showed that absence of retinopathy (OR: 0.451; 95% CI: 0.250–0.815; p < 0.001) and nephropathy (OR: 0.450; 95% CI: 0.212–0.951; p = 0.036) were independently associated with healing. Moreover, retinopathy was a predictor both of minor amputation (OR: 2.291; 95% CI: 1.061–4.949; p = 0.034) and mortality (OR: 5.274; 95% CI: 2.524–11.020; p < 0.001). Polyneuropathy never entered the regression model.
Conclusions
Diabetic microvascular complications, in particular retinopathy, may predict the outcomes of vascular DFU. Longitudinal studies should confirm this finding.
Similar content being viewed by others
References
K. Stoberock, M. Kaschwich, S.S. Nicolay, N. Mahmoud, F. Heidemann, H.C. Rieß et al. The interrelationship between diabetes mellitus and peripheral arterial disease. Vasa 50, 323–330 (2021)
C.E. Fife, S.D. Horn, R.J. Smout, R.S. Barrett, B. Thomson, A predictive model for diabetic foot ulcer outcome: the wound healing index. Adv. Wound Care (N. Rochelle) 5, 279–287 (2016)
R.J. Hinchliffe, R.O. Forsythe, J. Apelqvist, E.J. Boyko, R. Fitridge, J.P. Hong et al. International Working Group on the Diabetic Foot (IWGDF). Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab. Res. Rev. 36(Suppl 1), e3276 (2020)
C. Gazzaruso, P. Gallotti, A. Pujia, T. Montalcini, A. Giustina, A. Coppola, Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a ten-year retrospective cohort study. Endocrine 71, 59–68 (2021)
J.A. Beckman, M.S. Duncan, S.M. Damrauer, Q.S. Wells, J.V. Barnett, D.H. Wasserman et al. Microvascular disease, peripheral artery disease, and amputation. Circulation 140, 449–458 (2019)
C. Yang, L. Kwak, S.H. Ballew, B.G. Jaar, J.A. Deal, A.R. Folsom et al. Retinal microvascular findings and risk of incident peripheral artery disease: An analysis from the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 294, 62–71 (2020)
J.I. Shin, M.E. Grams, J. Coresh, A.R. Chang, K. Matsushita, Proteinuria and risk of lower-extremity amputation in patients with peripheral artery disease. Diabetes Care 42, e146–e147 (2019)
K.K.W. Olesen, S. Anand, T. Thim, C. Gyldenkerne, M. Maeng, Microvascular disease increases the risk of lower limb amputation - A Western Danish cohort study. Eur. J. Clin. Invest 52, e13812 (2022)
A. Behroozian, J.A. Beckman, Microvascular disease increases amputation in patients with peripheral artery disease. Arterioscler Thromb. Vasc. Biol. 40, 534–540 (2020)
American Diabetes Association, Retinopathy, neuropathy, and foot care: standards of medical care in diabetes—2022. Diabetes Care 45(Supplement_1), S185–S194 (2022)
C. Gazzaruso, A. Coppola, T. Montalcini, E. Baffero, A. Garzaniti, G. Pelissero et al. Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. Endocrine 41, 89–95 (2012)
C. Gazzaruso, A. Coppola, C. Falcone, C. Luppi, T. Montalcini, E. Baffero et al. Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. Diabetes Care 36, 1720–1725 (2013)
C. Gazzaruso, S.B. Solerte, A. Pujia, A. Coppola, M. Vezzoli, F. Salvucci et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J. Am. Coll. Cardiol. 51, 2040–2044 (2008)
W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugate. Clin. Chem. 18, 499–502 (1972)
D.W. Cockcroft, M.H. Gault, Prediction of creatinine clearance from serum creatinine. Nephron 16, 31–41 (1976)
C. Gazzaruso, A. Garzaniti, S. Giordanetti, C. Falcone, P. Fratino, Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism. Cardiovasc. Diabetol. 22, 1–5 (2002)
C. Gazzaruso, S.B. Solerte, E. De Amici, M. Mancini, A. Pujia, P. Fratino et al. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. Am. J. Cardiol. 97, 236–239 (2006)
C. Gazzaruso, A. Coppola, T. Montalcini, C. Valenti, G. Pelissero, S.B. Solerte et al. Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality in type 2 diabetic patients. Intern Emerg. Med 7, 257–266 (2012)
Società Italiana Diabetologia—Associazione Medici Diabetologi. Standard Italiani per la Cura del Diabete Mellito 2018. https://www.siditalia.it/pdf/Standard%20di%20Cura%20AMD%20-%20SID%202018.pdf (2018)
N.M. Hamburg, M.A. Creager, Pathophysiology of intermittens claudication in peripheral artery disease. Circ. J. 81, 281–289 (2017)
C. Falcone, S. Bozzini, L. Guasti, A. D’Angelo, A.C. Capettini, E.M. Paganini et al. Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease. ScientificWorldJournal 2013, 584504 (2013)
B.L. Johnson, M.H. Glickman, D.F. Bandyk, G.E. Esses, Failure of foot salvage in patients with end-stage renal disease after surgical revascularization. J. Vasc. Surg. 22, 280–285 (1995)
A. Caselli, V. Latini, A. Lapenna, S. Di Carlo, F. Pirozzi, A. Benvenuto et al. Transcutaneous oxygen tension monitoring after successful revascularization in diabetic patients with ischaemic foot ulcers. Diabet. Med. 22, 460–465 (2005)
A.J. Singer, R.A. Clark, Cutaneous wound healing. N. Engl. J. Med 341, 738–746 (1999)
B.M. Dulmovits, I.M. Herman, Microvascular remodeling and wound healing: a role for pericytes. Int J. Biochem Cell Biol. 44, 1800–1812 (2012)
S. Mätzke, F. Biancari, L. Ihlberg, A. Albäck, I. Kantonen, M. Railo et al. Increased preoperative c-reactive protein level as a prognostic factor for postoperative amputation after femoropopliteal bypass surgery for CLI. Ann. Chir. Gynaecol. 90, 19–22 (2001)
S. Siragusa, A. Malato, G. Saccullo, A. Iorio, M. Di Ianni, C. Caracciolo et al. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS studyAm. J. Hematol. 86, 914–917 (2011)
L. Zanoli, P. Boutouyrie, P. Fatuzzo, A. Granata, P. Lentini, K. Oztürk et al. Inflammation and aortic stiffness: an individual participant data meta-analysis in patients with inflammatory bowel disease. J. Am. Heart Assoc. 6, e007003 (2017)
A. Tuttolomondo, D. Di Raimondo, R. Pecoraro, C. Maida, V. Arnao, V. Della Corte et al. Early high-dosage atorvastatin treatment improved serum immune-inflammatory markers and functional outcome in acute ischemic strokes classified as large artery atherosclerotic stroke: a randomized trial. Med. (Baltim.) 95(13), e3186 (2016)
J. Barrot, J. Real, B. Vlacho, P. Romero-Aroca, R. Simó, D. Mauricio et al. Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes. Front Med. (Lausanne) 9, 945245 (2022)
X.H. Xu, B. Sun, S. Zhong, D.D. Wei, Z. Hong, A.Q. Dong, Diabetic retinopathy predicts cardiovascular mortality in diabetes: a meta-analysis. BMC Cardiovasc. Disord. 20, 478 (2020)
A. Pinto, A. Tuttolomondo, D. Di Raimondo, P. Fernandez, S. La Placa, M. Di Gati et al. Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot. Metabolism 57, 676–682 (2008)
A. Tuttolomondo, D. Di Raimondo, A. Casuccio, G. Guercio, A. Del Cuore, M.G. Puleo et al. Endothelial function, adipokine serum levels and white matter hyperintesities in subjects with diabetic foot syndrome. J. Clin. Endocrinol Metab jc.2018-02507 (2019)
A. Tuttolomondo, A. Del Cuore, A. La Malfa, A. Casuccio, M. Daidone, C.D. Maida et al. Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction. Cardiovasc Diabetol. 20, 142 (2021)
A. Tuttolomondo, S. La Placa, D. Di Raimondo, C. Bellia, A. Caruso, B. Lo Sasso et al. Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol. 9, 50 (2010)
A. Tuttolomondo, A. Casuccio, G. Guercio, C. Maida, A. Del Cuore, Di, D. Raimondo et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc Diabetol. 16, 2 (2017)
L. Wei, X. Sun, C. Fan, R. Li, S. Zhou, H. Yu, The pathophysiological mechanisms underlying diabetic retinopathy. Front Cell Dev. Biol. 10, 963615 (2022)
C.A. Ricciardi, L. Gnudi, Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies. Metabolism 124, 154890 (2021)
M.A. Elafros, H. Andersen, D.L. Bennett, M.G. Savelieff, V. Viswanathan, B.C. Callaghan et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol. 21, 922–936 (2021)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Ethical approval
This study was approved by the local Institutional Review Board.
Informed consent
This study used information previously collected during normal care (with no intention of using it for research purpose at the time of collection). The data set used was fully anonymized to the authors. Therefore, no informed consent was required from the patients for being included in the study.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gazzaruso, C., Montalcini, T., Gallotti, P. et al. Impact of microvascular complications on the outcomes of diabetic foot in type 2 diabetic patients with documented peripheral artery disease. Endocrine 80, 71–78 (2023). https://doi.org/10.1007/s12020-022-03291-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-022-03291-6